Tat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats by unknown
Harricharan et al. Behavioral and Brain Functions  (2015) 11:3 
DOI 10.1186/s12993-014-0047-3RESEARCH Open AccessTat-induced histopathological alterations mediate
hippocampus-associated behavioural impairments
in rats
Rivona Harricharan, Veneesha Thaver, Vivienne A Russell and William M U Daniels*Abstract
Background: HIV-1 is a global catastrophe, and is exceedingly prevalent in Sub-Saharan Africa. HIV-associated
neurocognitive disorder is characterized by symptoms such as motor impairments, a decline in cognition, and
behavioural irregularities. The aim of this study was to provide insight into the fundamental behavioural and
histopathological mechanisms underlying the development and progression of HIV-1 neuropathology.
Methods: Using stereotaxic techniques, Tat protein Clade B (1 μg/μl, 10 μl) was injected bilaterally into the dorsal
hippocampus of male Sprague–Dawley rats. The Morris water maze (MWM) and novel object recognition test (NORT)
were used to assess spatial learning and recognition memory, respectively. Haematoxylin and eosin staining was
used to identify the histopathological changes.
Results: A highly significant increase in latency to reach the hidden platform in the MWM implied that noteworthy
hippocampal damage had occurred. Severe behavioural deficits were also observed in the NORT where the Tat-injected
group showed a greater preference for a familiar object over a novel one. This damage was confirmed by
the histopathological changes (increased astrogliosis, cells becoming eosinophilic and a significant reduction
in the pyramidal cell layer) observed in the hippocampus. Additionally, increases in the hippocampal mass and protein
were observed, consistent with the structural alterations.
Conclusion: This study highlights the relationship between hippocampal-associated behavioural changes and histologic
alterations following stereotaxic intra-hippocampal administration of Tat protein in rats. The implications of this study
may positively impact the fields of immunology and neuroscience by encouraging future researchers to consider novel
strategies to understand the complexities of the pathogenesis of HIV-associated neurocognitive disorder.
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The prevalence of human immunodeficiency virus (HIV)
infection remains a global calamity, particularly in South
Africa where a prevalence rate of 4.6% has been reported
(World Health Organization Statistics, 2013). Parallel
to this concern is the escalating incidence of neuro-
cognitive impairments observed in patients living with
HIV. In a recent study Joska et al. (2010) reported
that 23.5% of HIV-positive individuals screened at HIV
clinics displayed some form of cognitive deficiency [1].* Correspondence: danielsw@ukzn.ac.za
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unless otherwise stated.Comparable prevalence rates have been documented
for HIV-positive populations elsewhere [2]. Despite this
alarming statistic only a few studies have focused on in-
vestigating the effects of HIV on brain function. Never-
theless important data have been forthcoming the past
two decades that have improved our understanding of
the disease. For instance HIV-associated neurocognitive
disorders may present with varying degrees of motor im-
pairment (such as tremor, impaired movement and prob-
lems associated with speech) and a progressive decline in
cognition (diminished memory function and difficulty as-
sociated with concentration) [3].
HIV-mediated dementia (HAD) has declined since
the employment of highly-active antiretroviral therapytral. This is an Open Access article distributed under the terms of the Creative
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of HIV-associated neurocognitive disorders (HAND) [4].
Prior to 1991, HAD was the only neurocognitive disorder
that had been defined. A refined and more accurate clas-
sification system for HAND was introduced in 2007
which categorized Mild Neurocognitive Disorder (MND)
and Asymptomatic Neurocognitive Impairment (ANI) as
two neurocognitive disorders in addition to HAD. Both
MND and ANI involve loss within at least two cognitive
areas however a patient with ANI does not display func-
tional impairment which is observable. With the rise in
the occurrence of MNI and ANI, the incidence of all
cases of HAND is estimated to be 40-50% [4]. Previous
studies have presented evidence that Tat protein is suffi-
cient to mediate cognitive and behavioural abnormalities
as seen in HIV-infected individuals and in animal models
of the disease [5,6]. Bruce-Keller et al. has shown that
genetically infusing C6 glioma cells into rat hippocampus
elicited Tat production subsequently resulting in damage
to neurons, impaired rotorod performance and increased
gliosis [7]. Additionally a study involving human brains
has shown that the hippocampus is one area particularly
vulnerable to damage during HIV-infection [8]. Despite
the high prevalence, the aetiology of the direct behav-
ioural effects caused by Tat on learning and memory has
not been fully elucidated.
The central nervous system acts as a reservoir for HIV
[9]. Interestingly, viral load has been shown to be a poor
indicator of the neuropathogenesis of HAND. Instead
the condition appears to correlate better with the activa-
tion of glia following the transendothelial migration of
infected macrophages into the brain [10]. Subsequent
neuronal injury may therefore result either directly or
indirectly from HIV-infected astrocytes and microglia
[3,9,11]. Astrocytes have the ability to release harmful
compounds (viral or cellular) or may influence neigh-
bouring cells (like microglia) to produce harmful com-
pounds which may damage neurons [4,12,13]. Whether
these responses of astrocytes and/or microglia cause the
deterioration in cognitive function associated with HIV
infection, remains uncertain.
The HIV genome includes three structural genes (gag,
pol, env), four accessory genes (vif, vpr, vpu, nef ) and
two regulatory genes (tat and rev) [14]. HIV-1 Tat
(Transactivator of transcription) is a multifunctional
protein in that it suppresses DNA polymerization, pro-
motes tRNA placement onto HIV RNA, alters chromatin
structure, phosphorylates RNA polymerase II and is re-
sponsible for viral gene transactivation [14]. Tat has also
been shown to be toxic to neurons [15-17]. Conse-
quently this viral protein has been implicated in instigat-
ing the behavioural changes that are observed with HIV
infection. However evidence to support this notion has
been limited [5].Humans usually access memory through the medium
of language (written, spoken, conceptual). However in
order to understand the effect of Tat protein on the cen-
tral nervous system (CNS) of animals, cognition must be
assessed through the variety of behaviours they exhibit
in response to different experimental paradigms, testing
their learning performance and memory capacity [18].
Several brain regions like the hippocampus are stimu-
lated in tests of memory and learning. The hippocampus
was discovered to play an indispensable role in spatial
memory in rats [19]. The Morris water maze (MWM)
and the novel object recognition test (NORT) are widely
accepted tests of spatial learning and recognition mem-
ory, respectively, in rats [18,20]. Since the NORT does
not employ positive (food) or negative reinforcement
(shock), it is considered to produce results that are com-
parable to memory tests in humans [20]. Elimination of
positive and especially negative reinforcement minimizes
stress of the animal and also removes confounding fac-
tors, thereby improving accuracy and reliability of the
data [20].
The aim of the present study was therefore to provide
further insight into the fundamental effects of Tat on the
central nervous system and to explore it as a possible
aetiological factor in the development of HIV-associated
neurocognitive disorder. We specifically focused on the
histopathological consequences of Tat injected directly
into the dorsal hippocampus of rats. The effects of the




A total of 25 adult male Sprague–Dawley rats (250-
300 g, approximately 2–3 months old) were used in this
study. To limit the confounding factors affecting our
study, male Sprague–Dawley rats were used to avoid the
effect of female hormones on the cells in the brain due
to the fact that during pro-oestrus, there is an increase
in cell proliferation which results in a greater number
of immature neurons in the hippocampus [21] which
would have affected the cellular morphology in our mi-
crographs. Furthermore, during pro-oestrous, dendritic
spine density is at its highest levels while the lowest
levels are observed in the oestrous phase [22]. Since
these changes were observed in the CA1 region of the
hippocampus, one of the areas of interest in the present
study, they could potentially have affected our results. In
a study by Korol et al. (2004), the authors claimed that
natural fluctuations of ovarian hormones can introduce
bias in the neural system causing it to favour certain cogni-
tive strategies [23]. During the pro-oestrous phase, rats
were likely to implement place strategies as opposed to the
estrous phase, where the rats favoured response strategies.
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Research Unit at the University of KwaZulu-Natal and
housed in this facility under standard laboratory condi-
tions of 23 ± 1°C, 70% humidity and a 12 h light–dark
cycle with lights on at 06 h00. The rats received food
(rat chow) and water ad libitum. Ethical approval for
the study was obtained from the Biomedical Research
Ethics Committee (Ethics approval number 067/11). Rats
were randomly divided into 2 groups namely a control
group and an experimental group. The cognitive abilities
of all the animals were assessed by subjecting them to be-
havioural tests (MWM and NORT) post injection of either
Tat protein or saline into their hippocampi.
Study design
The first 3 consecutive days (Day 1–3) were allocated to
MWM pre-injection training trials, followed by a test on
Day 4. On Day 5, the control animals received bilateral
0.9% Saline injections (10 μl) into their dorsal hippo-
campi, while the experimental animals were treated with
Tat (1 μg/μl, 10 μl). The animals were allowed to recover
over the next 3 days (Days 6–8). To determine the effect
of the intra-hippocampal administration of Tat on be-
haviour, post-injection trials were conducted for both
groups of animals. The post-injection MWM test 1 and
test 2 being performed on Day 9 and 12 respectively.
Object familiarization for the NORT occurred from Day
13–15 with the NORT conducted on Day 16. The ani-
mals were sacrificed on Day 17.
Stereotaxic surgery
Recombinant Tat Clade B was obtained from Diatheva
(Milan, Italy). Using stereotaxic techniques, Tat protein
Clade B (1 μg/μl, 10 μl) was injected bilaterally into the
dorsal hippocampus of the animals at the following co-
ordinates: −3.7 mm posterior to bregma, ± 2.6 mm from
the midline and 3.2 mm ventral to the surface of the
skull [24]. This concentration of Tat protein was chosen
since Gavriil et al. (2000) showed that injecting 20 μg of
Tat protein into the striatum was sufficient to induce
apoptosis [25]. Control animals were subjected to the
same procedure where they received an equal volume of
10 μl physiological saline (which served as the vehicle)
instead of Tat protein.
The rats were anaesthetized by injecting a standard
combination of pentobarbital and atropine at a dose of
60 mg/kg and 0.2 mg/kg respectively. After the surgery,
all animals were allowed to recover for 3 days before the
commencement of post-injection behavioural tests. Two
animals died during/after surgery (1 from the Saline-
injected group and 1 from the Tat-injected group).
Twelve days after the intrahippocampal injections,
six animals (three from the Saline group and three
from the Tat group) were anaesthetized and subjectedto transcardial perfusion with 4% paraformaldehyde in
phosphate buffered saline. Following perfusion, the brains
were harvested and stored in formalin for a minimum of
48 hours, to ensure adequate fixation.
Behavioural tests
Morris Water Maze (MWM)
The MWM assesses the learning and recollection ability
of rats involving the use of exploratory, navigational,
spatial and contextual memory [26]. The MWM consists
of a hidden platform located in one of the quadrants
of a 1 m diameter circular pool with a height of 85 cm
(Figure 1A). The platform was constructed of transpar-
ent plastic (11 × 11 cm and a height of 18 cm). The pool
was filled with tepid water (27 ± 1°C). There were fixed
visual cues attached to the walls of the pool as shown in
Figure 1A. In addition, distal cues were represented
by coloured sheets of paper attached to the walls of
the room as indicated by the pink and blue lines in
Figure 1B. The method entails placing the rat in a quad-
rant other than where a hidden platform is located and
then the time taken (latency) for the rat to find the hidden
platform is recorded. Each rat was released from three dif-
ferent quadrants and was allocated 120 seconds to find
the platform. If they were unable to do so, the rat was then
guided to the platform and allowed to remain on the
platform for 15 seconds. The rats participated in three
consecutive days of training pre-injection and the actual
pre-injection test was conducted on the fourth day with
the platform in the same place as during the trial days.
Post-injection test one and two was conducted four and
seven days after the injection respectively. For the post-
injection tests the platform was still located in the same
position as it was prior to the injection. In theory, the
control animals would learn the position of the hidden
platform quickly and hence they would need a short
time period to locate the hidden platform. In contrast,
cognitively impaired rats would be expected to take
longer to learn how to navigate to the hidden platform
and therefore they would require a longer time to lo-
cate it.
Novel Object Recognition Test (NORT)
The NORT was conducted to assess the rat’s ability to
recognize a novel object as determined by their explora-
tory behaviour. A normal rat’s curious nature should
cause it to display preference for exploring a novel ob-
ject over a familiar object. A large cage was used as the
arena for the test (52.5 cm × 35 cm). The familiarization
of animals to the experimental procedures occurred on
the first 3 days. On day 4 the test was done. On each
familiarization day the animals were first exposed to the
empty cage for 5 minutes, i.e. no objects present. The
animals were thus allowed to become familiar with the
Figure 1 The MWM room design and the performance of the Saline-injected rats and Tat-injected rats in the MWM. (A) A 3-dimensional
representation indicating the position of the platform in the MWM. (B) A simplified schematic diagram indicating the layout and the position of
the visual cues present in the room where the pool was located (Pink and Blue lines represent proximal and distal visual cues, the light grey and
dark rectangles represent a sink and table respectively, and the small square represents the position of the platform). Arrowheads represent the
different release points; (C) The decreasing latency in the Saline-injected rats persisted from pre-injection to post-injection; (D) Latency to find the
platform in the MWM was impaired in Tat-injected rats (Results are mean ± SEM). * Post-injection Tat significantly different from pre-injection Tat,
p < 0.05. *** Pre-injection trial 1 significantly different from Pre-injection test for the Tat group, p < 0.0001. (Saline: n = 9; Tat: n = 14).
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brief period, during which the two similar objects were
strategically placed according to Figure 2A. The removal
of animals from the cage was deemed important so as
not to attract their attention to the placement of the ob-
jects. The animals were given 10 minutes to explore
these objects. During this period we observed that the
animals were only “interested” in the objects in the first
2–3 minutes of exposure. On the following day, the
recognition test was done, involving one of the famil-
iar objects being exchanged for a novel object. This
was placed in the exact location as its predecessor
(Figure 2B). The time that each rat showed interest in the
objects (approaches and physical exploration), was only
recorded for the first 150 seconds (2.5 minutes). We de-
fined ‘investigating an object’ as referring to the animal in
close proximity to the object (<2 cm) and showing a dir-
ect interest in the object (meaning the animal interacting
directly with the object such as sniffing, pawing, licking,
moving or holding the object). We did not regard in-
stances where the animal walked past the object or was
in the vicinity of the object but not engaged in one of the
previously mentioned behaviours.Histology
Haematoxylin & eosin
Three brains from the Saline group and three brains
from the Tat-injected group were collected for histo-
logical analysis. The fixed brain was dehydrated, cleared
with xylene and infiltrated with paraffin. The tissue
was sectioned from a block approximately 6 mm thick
with the site of needle entry in the middle. The block
was trimmed and collection of sections occurred ap-
proximately 2 mm on both sides of the site of the
injection. The wax-embedded brain tissue was then
sectioned coronally into 3 μm sections using the rotary
microtome, Microm HM315. The slices were collected
on glass slides and immersed in increasing concentra-
tions of alcohol solutions (80%, 90% and absolute alcohol
twice) prior to being exposed to standard haematoxylin-
eosin staining techniques for 10 minutes. The slides
were subsequently placed in decreasing concentration
of alcohol and finally mounted in DPX permanent
mount. Photomicrographs of the slides and measure-
ments of the pyramidal cell layers were obtained
using the Leica SCN400 slide scanner (SMM Instruments,
South Africa).
Figure 2 The arena and performance in the NORT of the Saline-injected rats and Tat-injected rats. (A) The novel object test arena
displaying the familiar objects. (B) the novel object test arena displaying the novel object and one familiar object; (C) subject showing interest in
the familiar object; (D) subject showing interest in the novel object; (E) graphical representation of the time spent with the novel and familiar
objects by the saline- vs. Tat-injected groups. (Results are mean ± SEM). * Novel (Saline) significantly different from Familiar (Saline), p < 0.001.
** Novel (Tat) significantly different from Familiar (Tat), p < 0.01. (Saline: n = 9; Tat: n = 14).
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The animals were decapitated, the dorsal hippocampus
harvested and their wet weight recorded. The tissue was
stored temporarily in liquid nitrogen for subsequent
neurochemical analysis. Protein determination was done
according to the Bicinchoninic acid Assay (BCA) a
modification of the Lowry procedure. Briefly the hippo-
campal tissue samples were thawed and homogenized in
600 μl RIPA buffer using a sonicator. Following this pro-
cedure, the samples were centrifuged at 8000 g for 10 mi-
nutes at 4°C. The supernatant was extracted and then
further centrifuged again to ensure the samples were
clear. 50 ml of bicinchoninic acid solution (reagent A)
was mixed with 1 ml of Copper (II) sulfate pentahydrate
4% solution (reagent B) to make up the BCA working
reagent. Bovine serum albumin was used as the protein
standard. The actual procedure entailed the addition of
2 ml of the BCA Working Reagent to 0.1 ml of eachBSA protein standard and unknown sample. The stan-
dards and samples were gently vortexed and allowed to
incubate at 37°C for 30 minutes. 100 μl of each standard
and unknown sample was immediately transferred to a
96-well plate and the absorbance was measured at a
wavelength of 562 nm.
Statistical analysis
GraphPad Prism 5 (Graph Pad Software Inc., USA) was
used to perform statistical analysis of the data where a
p value < 0.05 was considered statistically significant.
Tests for normality were conducted using the D’Agostino
& Pearson omnibus normality test. The MWM data
were found to have a non-Gaussian distribution. Sub-
sequently non-parametric methods were used to ana-
lyse this data. Differences within the same group were
assessed with the Kruskal-Wallis test followed by
Dunn’s Multiple Comparison post-hoc test. Differences
Figure 3 Graphical representation showing the changes in the
pyramidal cell layer in the CA 1/2 and CA 3/4 regions in the
Saline-injected and Tat-injected groups (Results are mean ± SEM).
*** Tat is significantly lower than Saline, p < 0.001. (Saline: n = 3,
Tat: n = 3).
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was analysed using independent t-tests. The NORT data
were analysed using one-way ANOVA with Bonferroni
post-hoc test. Independent t-tests were used to analyse
changes in the thickness of the pyramidal cell layer for the
Saline-injected (n = 3) and Tat-injected (n = 3) groups.
The hippocampal mass and protein levels were also
analysed using independent t-tests (Saline: n = 6, Tat:
n = 9). Data are presented as the mean ± standard error of
the mean (SEM).
Results
Kruskal-Wallis test and Dunn’s Multiple Comparison
post-hoc test revealed significant differences in the la-
tency to find the platform between pre-injection and
post-injection tests in the Tat-injected group. Latency to
find the platform decreased post-injection in the Saline-
injected rats (Figure 1C). Latency to find the plat-
form increased post-injection in the Tat-injected group
(Figure 1D). Analysis of the data obtained in the MWM
prior to the injection of saline or Tat revealed no statisti-
cally significant difference between the latencies of the
Saline-injected and Tat-injected groups. However, ana-
lysis of the latencies to reach the hidden platform post in-
jection showed that there was a statistically significant
difference between the latencies of the Saline-injected
and Tat-injected rats (p < 0.05).
One-way ANOVA revealed a significant difference in
time spent exploring the novel object compared to the
familiar object (F(3,42) =14.07; p < 0.05). Saline-injected
rats spent more time with the novel object than with the
familiar object (p < 0.001) while Tat-injected rats spent
less time with the novel object than with the familiar ob-
ject (p < 0.01, Figure 2E). Based on the results depicted
in Figure 2E, animals within the Saline group demon-
strated a preference for the novel object over a familiar
one. In contrast, the Tat-injected group showed greater
preference for the familiar object by spending more time
investigating the familiar object than the novel object as
shown in Figure 2E. Saline-injected rats spent a greater
amount of time investigating a novel object than the
Tat-injected group (p < 0.05). The Tat-injected rats spent
more time with a familiar object than the Saline-injected
group (p < 0.001).
We observed a statistically significant reduction in the
pyramidal cell layer thickness (particularly in CA 1/2
and CA 3/4 regions) of the hippocampus of the Tat-
injected rats in comparison to the Saline-injected group.
This analysis was conducted using independent t-tests to
analyse the data (p < 0.001, Figure 3). Figure 4A-E shows
the histological differences between the Saline-injected
and Tat-injected rat hippocampus. The Tat-injected
hippocampi exhibited darker staining in comparison
to the Saline-injected group. Gliosis was also observed inthe Tat-injected hippocampal tissue. The astrocytes in
the Saline-injected group had discernible “naked” nuclei
whereas the Tat-injected group showed reactive astro-
cytes (which were considerably larger in size) with more
prominent hyperchromatic nuclei that had been dis-
placed to the periphery.
Independent t-tests showed that the hippocampal
mass of the Tat-injected rats was significantly greater
than that of the Saline-injected rats (p < 0.05, Figure 5A).
This was corroborated by the increase in hippocampal
protein concentration of the Tat-injected rats compared
to the Saline-injected rats (p < 0.01, Figure 5B).
Discussion
Despite the administration of antiretroviral therapy,
many HIV-infected individuals go on to develop cogni-
tive impairments [27]. The likelihood of these alterations
in brain function stemming from HIV is supported by
the fact that the brain serves as a reservoir for the virus
during latent periods [9]. We hypothesized that the viral
protein Tat and not the intact virus may be adequate to
induce cognitive abnormalities in mammals. To test this
hypothesis we injected Tat directly into the hippocampi
of rats and assessed the impact thereof on the cognitive
behaviour of the animal. The brain tissue in the area of
the injection sites was also histologically analysed to de-
termine the effect of Tat on cellular morphology.
The Saline-injected group displayed normal learning
patterns both pre- and post-hippocampal injections. This
is consistent with results obtained for a Saline-treated
group in a study by Meilandt et al. (2004) where their
Saline-treated group displayed learning curves similar to
Saline-injected rats in the present study [28]. The de-
crease in latency to find the platform in the second post-
injection test of the Saline-injected group demonstrated
their ability to learn and re-call the task more quickly
Figure 4 Photomicrograph of haematoxylin and eosin stained Saline and Tat sections. Photomicrograph of haematoxylin and eosin
stained Saline and Tat sections (A) hippocampal formation and dentate gyrus of a Tat-injected brain (200×). White arrow represents the path of
the tract created by the needle and the ‘x’ indicates the site of injection, Scale bar = 200 μm; (B) the pyramidal cell layer (PC) in a Saline-injected
rat brain Post-injection (100×), Scale bar = 100 μm; (C) the pyramidal cell layer (PC) in a Tat-injected brain Post-injection (100×), Scale bar = 100 μm;
(D) Neurons and glial cells in the Saline-injected brain (50×); White arrows represent normal astrocytes, Scale bar = 50 μm; (E) Neurons and glial cells
in the Tat-injected brain (50×). Yellow arrows show astrocytes undergoing gliosis, Scale bar = 50 μm.
Figure 5 The hippocampal mass and protein concentration of the Saline and Tat groups. Graphical representation of (A) hippocampal
mass of the Saline-injected and Tat-injected groups. (B) hippocampal protein of the Saline-injected and Tat-injected groups (Results are mean ± SEM).
* Saline is significantly lower than Tat, p < 0.05, ** p < 0.01. (Saline: n = 6, Tat: n = 9).
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their fastest times post-injection. This confirmed that
the mechanical damage caused by administration of sa-
line did not impair the learning-associated function of
the hippocampus. The Tat-injected group showed nor-
mal learning curves prior to injection depicting the ani-
mal’s ability and mental capacity to learn the task and
effectively exploit spatial and navigational cues allowing
them to complete the task. Assessment of post-injection
learning and recollection of the task showed that Tat sig-
nificantly impaired the functioning of the hippocampus.
The latency of the Tat-injected group to reach the plat-
form markedly increased after the injection, demonstrat-
ing that intra-hippocampal administration of Tat directly
affected the rat’s learning ability and performance of
a spatial learning acquisition task. These results are
in agreement with those reported by Fitting et al.
(2008a, b) who showed that intrahippocampal injections
of Tat on postnatal day 1 impaired spatial memory and
decreased the number of neurons in the dentate gyrus at
7 months of age, while increasing the number of astro-
cytes and oligodendrocytes [29,30]. More recently, Fitting
et al. (2013) also showed that Tat transgenic mice dem-
onstrated an increased latency to find the hidden plat-
form in the MWM [31]. Learning and memory are two
functions that are innately associated with the dorsal
hippocampus of the rat. Many studies have shown that
damage to the hippocampus leads to deficits in learning
and memory [32-35]. Our results therefore confirm these
learning impairments. While several studies [36-38] in-
cluding our study have placed emphasis on decreasing
escape latencies as a measure of learning, it should also
be noted that even blind animals may display decreased
latencies [39]. Path length (which highlights searching
behaviour) is also an important factor to consider.
Animals within the Saline-injected group displayed a
preference for the novel object after three days of expos-
ure to a familiar object. This is in agreement with
published results involving mice [5]. In contrast, the
Tat-injected group spent greater exploratory time investi-
gating the familiar object in comparison to the novel ob-
ject. Our findings are in agreement with a study by
Torres & Noel (2014) who demonstrated that rats in-
fected with HIV-1 viral protein R (Vpr) spent greater
time exploring a familiar object over a novel one [40].
According to Ennaceur (2010), experimental rodents may
experience difficulty in remembering the familiar object
and perceive the familiar object as “novel” or “vaguely
familiar”. This results in the experimental animals spend-
ing more time exploring the familiar object as opposed to
the control animals who recognize the familiar object as
being recently encountered [41]. Our results further sug-
gest that the hippocampal impairment was due to the ef-
fect of the Tat and not as a result of mechanical damagecaused by the needle tract or the procedure of the actual
intrahippocampal injection itself. Similar to the present
findings, Antunes & Biala, (2012) found that animals with
hippocampal damage unintentionally express their pref-
erence for a familiar object rather than a novel object due
to their reduced cognitive skills to recognize the novelty
of the new object introduced [18]. Due to the great im-
portance for rats to exhibit exploratory behaviour and
their curious nature, normal and healthy rats would dis-
play a greater preference for a novel object.
In a recent clinical study Ortega et al. (2013) used
neuropsychological tests and neuroimaging techniques
to demonstrate a significant reduction in the volume of
brain areas of HIV-positive patients that included the
hippocampus, when compared to age-matched controls
[42]. The decreases in brain volumes correlated well
with the poor performances of the infected patients in
the neuropsychological tests [42]. Comparably, we mea-
sured the weights and protein content of the hippocampi
of the two groups of animals. We found that in contrast
to expectation the Tat-injected hippocampi had a greater
mass and total amount of protein in comparison to the
Saline-injected group. A number of studies have shown
that tat injected directly into the brain leads to various
neurochemical abnormalities [15-17]. These included
Tat-mediated NMDA receptor activation, dysregulation
of calcium homeostasis, generation of reactive oxygen
species, and activation of death-inducing signalling path-
ways with the initiation and execution of apoptotic cell
death. With effects such as these one would expect Tat
toxicity to lead to a reduction in protein concentration
and tissue mass. However this was not the case in our
study. A probable mechanism for the increase in protein
content may involve the ubiquitin-proteosome system.
Through protein ubiquitination damaged intracellular
proteins are recognized and degraded to remove any
potential danger for the cell. However the ubiquitin-
proteosome system may also serve as a regulator of gene
expression through the controlled destruction of cyclins,
protein kinases and transcription factors. Production or
accumulation of protein aggregates leads to disruption of
the ubiquitin-proteosome system when these aggregates
are deposited into cytoplasmic inclusion bodies [43]. Pro-
tein aggregate accumulation is a globally-recognized fea-
ture of several hereditary and sporadic neurodegenerative
diseases [44], substantiating the hypothesis that the aggre-
gation is an underlying molecular mechanism in neurode-
generative disease pathogenesis [45]. Ubiquitination has
been shown to stimulate the transcriptional properties of
Tat protein and ubiquitin plays a non-proteolytic function
following its fusion to Tat protein [46]. This process may
have accounted for the increase in protein content.
The increase in protein content may have disturbed
proteostasis (protein homeostasis) within the endoplasmic
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degradation of proteins. This occurs via the unfolded pro-
tein response (UPR) pathway. The role of the adaptive
UPR pathway is to ensure that the ER is functioning ad-
equately, while the apoptotic UPR pathway functions to ex-
terminate cells subjected to chronic or rigorous ER stress.
Dysregulation of the UPR system instigates the occurrence
of oxidative stress consequently resulting in the induction
of apoptosis. Based on the histopathology, we observed
pyknotic nuclei, a common characteristic of apoptosis. It is
therefore not surprising that dysfunction of the UPR sys-
tem leading to the loss of pyramidal cells via apoptosis may
have occurred in our Tat-induced rat model of HAND be-
cause of the emerging importance of improper functioning
of the UPR system in the development of neurodegenera-
tive diseases [47].
Histological analysis of the hippocampi of the Saline-
injected group displayed features of a healthy, normal
hippocampal formation whereas the Tat-injected group
showed distinct differences. The pyramidal cells and
areas of the hippocampus located near the dentate gyrus
in the Tat-injected group appeared darker in the photo-
micrograph as compared to that of the saline-injected
group. A possible explanation for this difference may
stem from glial cells (like astrocytes) undergoing gliosis.
During this process the pH of the cellular microenviron-
ment decreases to become more eosinophilic. This lower
pH increases the cell’s affinity for the haematoxylin and
eosin stain and may lead to the darker colour intensity
[48]. Normal astrocyte cytoplasm is usually discernible
with haematoxylin and eosin staining. The Tat-infected
brains displayed reactive astrocytes with more promin-
ent hyperchromatic nuclei which had been displaced to
the periphery. This finding was consistent with the ob-
servations of Aschner & Costa (2004) who described the
cytoplasm of astrocytes to become more distinct by 7–
10 days following an insult [49]. Interestingly these au-
thors also reported astrocyte proliferation in addition to
its hypertrophy. Productive infection or infection by the
whole virus is not required to induce alteration in the
BBB. Tat can effectively be translocated into the CNS by
means of the BBB [14]. Cytokines like TNF-α have been
implicated in regulation of synaptic plasticity in neuro-
pathological states subsequently resulting in memory
and learning deficits [50]. This is consistent with the
neurological deficits associated with HIV-mediated neu-
rocognitive disorders. Tat elicits its secondary effects,
commencing with cytokine production within the CNS
which consequently results in glial activation first and
then attracts the infiltration of monocytes into the brain
[51]. TNF-α along with other cytokines enhance astrocy-
tosis/astrogliosis, a process that occurs frequently in
HIV-mediated neurocognitive disorders where there is
an increase in the size and quantity of astrocytes [52].Activated macrophages are attracted by astrocytosis [3].
Increased cytokine production in the periphery only oc-
curs subsequently after the activation of glia. Fiala et al.,
(1997) found that early after the infection, the brain is
protected from HIV-1 by the BBB [51]. However cyto-
kines like TNF-α open a paracellular route into the
brain. Since there have been several studies involving
the immune response and cytokine production initiated
by Tat protein, this study elaborates on the behavioural
and histopathological aspects which have not been fully
understood.
Another prominent histological difference observed
between saline-injected and Tat-injected brains was the
thickness of the pyramidal cell layer. In saline-treated
controls the pyramidal cell layer consisted of 5–6 cells in
thickness (approximately 40 μm in the CA 1/2 region
and 63 μm in the CA 3/4 region) forming distinct layers
as opposed to the significant perturbation of the pyram-
idal cell layer in the Tat-injected brain where it only con-
sisted of 2–3 cells in thickness (approximately 23 μm in
the CA 1/2 region and 45 μm in the CA 3/4 region).
This suggested that Tat caused a loss of pyramidal neu-
rons, an observation that was in agreement with data of
Kaul and Lipton (2006) who found that exposure to
HIV-1 proteins does indeed cause extensive loss of pyr-
amidal neurons [53]. Our results are further supported
by Bell et al. (2003) who showed that an increase in
gliosis is often associated with microtubule loss and sub-
sequent neuronal loss in the CA3 region of the hippo-
campus and the dentate gyrus in animals following
exposure to viral proteins of HIV [54]. Since Tat is the
only viral protein known to be released by infected
microglial cells [55] it may have accounted for the in-
creased protein concentration as we have shown that
active gliosis is occurring and this process occurs subse-
quently after activation of the macro- and microglia,
however this is only our speculation. The fact that Tat-
treated animals had greater hippocampal mass suggested
that the increase in astrogliosis superceded the rate of
neuronal loss at this stage of disease pathogenesis. We
therefore speculate that while the degree of neuronal
loss was insufficient to be reflected in atrophy of the
hippocampus, it was adequate to induce impaired cogni-
tive function.
Conclusion
In this study, we have shown that direct injection of Tat
protein into the hippocampus of rats may lead to learning
and memory deficits in these animals. This impairment in
cognitive behavior was associated with significant abnor-
malities in the microarchitecture of the hippocampus. Al-
though several recent studies have shown Tat protein to
be a promising candidate for a vaccine in HIV infection
[56,57], we were interested in examining its adverse
Harricharan et al. Behavioral and Brain Functions  (2015) 11:3 Page 10 of 11effects. In this particular study, we investigated the early
stages of the HIV-1 infection but in future, we suggest that
extending the time frame of the study could assist in bet-
ter comprehension of the disease progression. The impli-
cations of this study may positively impact the fields of
immunology and neuroscience. In the field of Neurosci-
ence, the escalating volume of research continues to gen-
erate novel findings. These discoveries offer promising
new targets for therapeutic interventions and possibly a
way to reduce the damage caused by HAND. These novel
findings only arise through comprehensive understanding
of the neurological and immunological factors which
influence the etiological mechanisms involved in HIV-
related neurocognitive disorders.
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